People who often experience overwhelming fatigue, unrefreshing sleep, cognitive difficulties, pain, and a variety of autonomic and sensory disturbances may be suffering from myalgic ...
LOS ANGELES, April 8, 2024 /PRNewswire/ -- Solve M.E., the leading organization dedicated to advancing medical research and patient advocacy since 1987, is pleased to announce that Emily Taylor, Vice ...
The Solve ME/CFS Catalyst Award-winning studies will fast-track clinical and immunological studies aimed at delivering new treatment strategies and diagnostic insights for ME/CFS and Long Covid, ...
Global Healthcare Industry Veteran Plans to Leverage Extensive Advocacy Experience, Rare Disease Expertise, and a History of Creating Important Public-Private Partnerships to Benefit ME/CFS Patients; ...
The Catalyst Award will expedite the hunt for a validated test-to-treat model for ME/CFS, a disease for which there is currently no FDA-approved treatment. LOS ANGELES, June 17, 2025 /PRNewswire/ -- ...
LOS ANGELES, April 29, 2025 /PRNewswire/ -- Solve M.E., the Brain Inflammation Collaborative (BIC), ChronicleBio, the Complex Disorders Alliance, and CareEvolution have launched a powerful new ...
New Catalyst Award funds high-impact research by Dr. Akiko Iwasaki, accelerating breakthroughs for millions. Solve M.E. is a national nonprofit dedicated to making myalgic encephalomyelitis/chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results